Trial intelligence / Profile preview

Evaluation of three treatments for uncomplicated Plasmodium vivax malaria

RBR-79s56sPhase 3Recruiting

Sponsor
Fundação Oswaldo Cruz
Start
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of chloroquine, primaquine, artesunate, mefloquine, artemether and 1 more in malaria, sponsored by Fundação Oswaldo Cruz. Started Aug 2012; status: recruiting.

02

Drugs

chloroquineprimaquineartesunatemefloquineartemether
03

Conditions

malaria

Beyond the preview

Go deeper on RBR-79s56s.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-79s56s.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call